112 related articles for article (PubMed ID: 27552622)
41. Hysterectomy in obese women: a comparison of abdominal and vaginal routes.
Isik-Akbay EF; Harmanli OH; Panganamamula UR; Akbay M; Gaughan J; Chatwani AJ
Obstet Gynecol; 2004 Oct; 104(4):710-4. PubMed ID: 15458890
[TBL] [Abstract][Full Text] [Related]
42. Regional and temporal variation in hysterectomy rates and surgical routes for benign diseases in the Netherlands.
Hanstede MM; Burger MJ; Timmermans A; Burger MP
Acta Obstet Gynecol Scand; 2012 Feb; 91(2):220-5. PubMed ID: 22043840
[TBL] [Abstract][Full Text] [Related]
43. Laparoscopic versus vaginal hysterectomy for benign indications in women aged 65 years or older: propensity-matched analysis.
Bogani G; Cromi A; Uccella S; Serati M; Casarin J; Pinelli C; Lazzarini C; Ghezzi F
Menopause; 2015 Jan; 22(1):32-5. PubMed ID: 24977457
[TBL] [Abstract][Full Text] [Related]
44. Laparoscopic supracervical hysterectomy with transcervical morcellation: initial experience.
Rosenblatt P; Makai G; DiSciullo A
J Minim Invasive Gynecol; 2010; 17(3):331-6. PubMed ID: 20417424
[TBL] [Abstract][Full Text] [Related]
45. Safe vaginal uterine morcellation following total laparoscopic hysterectomy.
Günthert AR; Christmann C; Kostov P; Mueller MD
Am J Obstet Gynecol; 2015 Apr; 212(4):546.e1-4. PubMed ID: 25460836
[TBL] [Abstract][Full Text] [Related]
46. Operating time and blood loss during laparoscopic-assisted vaginal hysterectomy with in situ morcellation.
Chou LY; Sheu BC; Chang DY; Chen SY; Huang SC; Hsu WC; Chang WC
Acta Obstet Gynecol Scand; 2011 Sep; 90(9):985-9. PubMed ID: 21615713
[TBL] [Abstract][Full Text] [Related]
47. Hysterectomy rates for benign indications.
Jacobson GF; Shaber RE; Armstrong MA; Hung YY
Obstet Gynecol; 2006 Jun; 107(6):1278-83. PubMed ID: 16738152
[TBL] [Abstract][Full Text] [Related]
48. [Vaginal hysterectomy wins].
Flam F; Lundberg S
Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2167-9. PubMed ID: 17824370
[No Abstract] [Full Text] [Related]
49. Peripartum cesarean hysterectomy: critical analysis of risk factors and trends over the years.
Orbach A; Levy A; Wiznitzer A; Mazor M; Holcberg G; Sheiner E
J Matern Fetal Neonatal Med; 2011 Mar; 24(3):480-4. PubMed ID: 20636233
[TBL] [Abstract][Full Text] [Related]
50. Alterations in surgical technique after FDA statement on power morcellation.
Desai VB; Guo XM; Xu X
Am J Obstet Gynecol; 2015 May; 212(5):685-7. PubMed ID: 25735888
[No Abstract] [Full Text] [Related]
51. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure.
Mazdisnian F; Kurzel RB; Coe S; Bosuk M; Montz F
Obstet Gynecol; 1995 Jul; 86(1):60-4. PubMed ID: 7784024
[TBL] [Abstract][Full Text] [Related]
52. An audit on hysterectomy for benign diseases in public hospitals in Hong Kong.
Leung PL; Tsang SW; Yuen PM;
Hong Kong Med J; 2007 Jun; 13(3):187-93. PubMed ID: 17548906
[TBL] [Abstract][Full Text] [Related]
53. Hysterectomy trends in Australia--between 2000/01 and 2004/05.
Hill EL; Graham ML; Shelley JM
Aust N Z J Obstet Gynaecol; 2010 Apr; 50(2):153-8. PubMed ID: 20522072
[TBL] [Abstract][Full Text] [Related]
54. Use of morcellation to remove fibroids scrutinized at FDA hearings.
Hampton T
JAMA; 2014 Aug; 312(6):588. PubMed ID: 25117116
[No Abstract] [Full Text] [Related]
55. A comparison of abdominal and vaginal hysterectomy for the large uterus.
Harmanli OH; Gentzler CK; Byun S; Dandolu MH; Grody T
Int J Gynaecol Obstet; 2004 Oct; 87(1):19-23. PubMed ID: 15464771
[TBL] [Abstract][Full Text] [Related]
56. Abdominal and vaginal radical hysterectomy among U.S. women aged 65 years and older.
Amini SB; Weight SA; Yuan Z; Rimm AA
Int J Technol Assess Health Care; 1996; 12(2):377-87. PubMed ID: 8707508
[TBL] [Abstract][Full Text] [Related]
57. The marketing effect.
Dietl J
Dtsch Arztebl Int; 2010 Nov; 107(45):796; author reply 797-8. PubMed ID: 21124699
[No Abstract] [Full Text] [Related]
58. Hysterectomy among women of reproductive age, United States, update for 1981-1982.
Irwin KL; Peterson HB; Hughes JM; Gill SW
MMWR CDC Surveill Summ; 1986; 35(1):1SS-6SS. PubMed ID: 3086700
[No Abstract] [Full Text] [Related]
59. Hysterectomy among women of reproductive age, United States, update for 1979-1980.
Sattin RW; Rubin GL; Hughes JM
MMWR CDC Surveill Summ; 1983 Aug; 32(3):1SS-7SS. PubMed ID: 6656831
[No Abstract] [Full Text] [Related]
60. Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration.
Redberg RF; Jacoby AF; Sharfstein JM
JAMA; 2017 Jul; 318(4):325-326. PubMed ID: 28662227
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
